TrialInternational journal of chronic obstructive pulmonary disease2020

Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis.

Henrik Watz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.